Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Dr. Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Dr. Michel Manika Muteya, Faculty of Medicine, University of Lubumbashi, Congo, Democratic Republic of the

Dr. Michel Manika Muteya is a seasoned Congolese physician, specializing in Anesthesiology, Intensive Care, and Emergency Medicine. Born in Lubumbashi on September 5, 1972, he has dedicated over two decades to both clinical excellence and academic research. As Head of the Anaesthesiology-Intensive Care Department at the University Teaching Hospital of Lubumbashi since 2013, Dr. Muteya is recognized for advancing critical care practices in resource-limited settings. His scientific contributions, spanning over 20 peer-reviewed publications, tackle pressing health issues like sepsis, tuberculosis, transfusion medicine, and maternal care. A married father of five, he balances his demanding career with strong family values. With a collaborative spirit and global engagements, he contributes to large-scale studies including the ASOS-2 Lancet Trial, reflecting his impact in African surgical safety. His leadership and evidence-based approach make him a top contender for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Michel Muteya Manika received his Doctor of Medicine (MD) degree after completing an intensive medical program that included a year-long rotating internship (2003–2004) at Sendwe Hospital in Lubumbashi, covering internal medicine, pediatrics, surgery, and gynecology. He further honed his skills through a professionalization internship in General Medicine at the Ruashi Military Hospital (HMR) from November 2004 to May 2005. His specialization journey led him into the field of Anesthesiology and Intensive Care, where he developed key competencies in transfusion medicine, disaster medicine, and emergency response. In parallel, he has continually upgraded his academic profile by engaging in international conferences, research collaborations, and multi-country studies. His educational path reflects a strong clinical foundation coupled with academic curiosity, enabling him to bridge practical medicine with impactful research in sub-Saharan Africa.

Experience:

Dr. Michel Manika Muteya has served as the Head of Anaesthesiology and Intensive Care at the University Teaching Hospital of Lubumbashi since 2013. His leadership has driven improved patient outcomes and department-wide protocols, especially for sepsis, trauma, obstetric emergencies, and postoperative care. His hands-on training began with internships in internal medicine, pediatrics, surgery, and gynecology, followed by a professionalization period at a military hospital. With more than 20 years of clinical and academic experience, Dr. Muteya has also contributed to policy and training reforms in anesthesia education, collaborating with international teams in Rwanda and beyond. He’s a mentor, educator, and published researcher, involved in critical studies related to infectious diseases, HIV, malaria, and emergency care readiness. His commitment to healthcare in resource-limited environments underlines his passion for equitable, safe, and effective care, making his career a beacon of medical excellence in Central Africa.

Research Focus:

Dr. Michel Muteya Manika’s research primarily focuses on critical care medicine in low-resource settings, with specific interests in sepsis management, transfusion medicine, anesthetic safety, and infectious diseases such as tuberculosis and HIV. He investigates both the clinical and epidemiological aspects of disease patterns in the Democratic Republic of Congo, often exploring how infrastructure limitations affect care outcomes. His work extends to maternal and pediatric emergencies, post-operative surveillance, and clinical education reform, including developing curricula for anesthesiology clerkships in Africa. He collaborates widely across disciplines and borders, contributing to high-impact journals like The Lancet Global Health, BMC Health Services Research, and Pan African Medical Journal. A champion of evidence-based practice, Dr. Muteya seeks to align global standards with local realities, enhancing emergency response systems and training the next generation of African clinicians. His applied, context-specific research offers real-world solutions to systemic healthcare challenges.

Publications Top Notes: 

  1.  Prognosis of Tetanus Patients in ICU – Sendwe Hospital, Lubumbashi

  2.  Epidermoid Carcinoma of the Vulva in Twin Pregnancy – Case Report

  3.  Tuberculosis Revealed by Thrombocytopenic Purpura in a Child

  4.  Anemias in Pediatric Emergencies – 632 Cases Study

  5.  Peripheral Lymphadenopathy: Tertiary Center Study

  6.  Cytopathological Profile of Lymphadenopathies – 13 Cases

  7.  Malaria/HIV Coinfection Profile in Lubumbashi Adults

  8.  Seroprevalence of Blood Donors – University Clinics of Lubumbashi

  9.  Tuberculosis Profile in Lubumbashi Health Zone

  10.  Anesthesia Practices in Lubumbashi – Patient and Surgery Types

Conclusion:

Dr. Michel Manika Muteya is highly suitable for the Best Researcher Award. He combines clinical leadership, regional relevance, and consistent academic output in fields critical to healthcare improvement in Africa. His research addresses real-world health crises—sepsis, HIV, TB, surgical safety—through practical, evidence-based approaches. With a balance of hands-on expertise and scholarly excellence, he represents the ideal candidate whose work has both academic rigor and societal impact. Minor expansions in global visibility and technological integration would elevate his already impressive career to even greater heights.

Yanhe Han | Microbial Cell Biology | Best Researcher Award

Prof. Yanhe Han | Microbial Cell Biology | Best Researcher Award

Prof. Yanhe Han, Beijing Institute of Petrochemical Technology, China

Dr. Han Yanhe is an accomplished environmental engineer and Associate Professor at Beijing Institute of Petro-Chemical Technology, China. With over 20 years of academic and research experience, Dr. Han has focused on cutting-edge wastewater treatment technologies, such as electrochemical catalytic oxidation and micro-electrolysis. A Ph.D. graduate from Dalian University of Technology, his work bridges practical environmental challenges and sustainable engineering solutions. Internationally recognized, Dr. Han completed a research fellowship at Griffith University, Australia, expanding his global academic footprint. His research has led to over 15 high-impact publications, addressing pollutant degradation, water quality detection, and novel electrode materials. In addition to research, he teaches core subjects like water pollution control and environmental quality assessment, nurturing the next generation of environmental scientists. Dr. Han’s integrated approach to technology development and practical applications places him at the forefront of environmental research in China and globally.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Innovative Research Excellence
    Dr. Han is a leader in environmental engineering, particularly in the development of electrochemical and micro-electrolysis technologies for advanced wastewater treatment. His innovations target real-world environmental challenges, such as industrial wastewater degradation, phosphorus removal, and simultaneous pollution treatment and energy recovery.

  2. Prolific Academic Output
    With over 15 peer-reviewed international publications, many in top-tier journals such as Journal of Hazardous Materials, Separation and Purification Technology, and Chemical Engineering Journal, Dr. Han has established a strong global academic presence.

  3. Interdisciplinary & Application-Oriented Work
    His research integrates environmental science, electrochemistry, and materials engineering — demonstrating a rare interdisciplinary depth and high potential for real-world application, especially in energy-efficient and sustainable water treatment systems.

  4. Global Experience & Recognition
    His research fellowship at Griffith University, Australia, reflects international collaboration and visibility, reinforcing his status as a globally competent researcher.

  5. Teaching and Mentorship
    Dr. Han is committed to education, offering over a decade of university-level teaching experience in core environmental engineering subjects, while mentoring new researchers in practical and theoretical aspects of the field.

Areas for Improvement:

  • International Research Collaboration
    While his research is impactful, greater involvement in international joint projects, EU or UN-led sustainability frameworks could amplify his global research influence.

  • Industry-Academic Partnerships
    Collaborations with industrial partners for pilot-scale or commercial deployment of his technologies could enhance technology transfer and societal impact.

  • Research Visibility and Citations
    Actively promoting his work through keynote talks, media, or open-access platforms may further boost citations and recognition.

Education:

Dr. Han Yanhe earned his Ph.D. and Master’s degrees in Environmental Engineering from the School of Environmental and Biological Science & Technology at Dalian University of Technology (2001–2006). His research focused on the electrochemically enhanced adsorption of organic pollutants using activated carbon fibers, reflecting a strong foundation in both theoretical and applied chemistry. Before that, he obtained his Bachelor’s degree in Environmental Engineering from Xi’an University of Engineering Science & Technology (1997–2001), where he gained fundamental skills in chemical processes and pollution control. His education reflects a consistent trajectory in environmental sciences, building both his research capabilities and practical engineering knowledge. These academic qualifications have shaped his expertise in advanced wastewater treatment technologies and environmental monitoring systems, forming the core of his research and professional contributions in later years.

Experience:

Dr. Han Yanhe is currently an Associate Professor at Beijing Institute of Petro-Chemical Technology (since 2011), where he leads research in electrochemical wastewater treatment and teaches environmental engineering. He was previously a Research Fellow at Griffith University, Australia (2009–2011), contributing to international research in water pollution control. From 2006 to 2009, Dr. Han served as Senior Lecturer and later Associate Professor at Liaoning Normal University. Across these roles, he has developed innovative technologies for water treatment, including internal circulation micro-electrolysis reactors and pollutant degradation methods. His leadership in both academic and research domains is evident through a strong publication record, supervision of student research, and cross-disciplinary project involvement. His international and domestic experience underscores a deep commitment to solving environmental challenges through sustainable technologies.

Research Focus:

Dr. Han Yanhe’s research centers on advanced wastewater treatment and environmental monitoring. His primary areas include electrochemical catalytic oxidation, iron-carbon micro-electrolysis, and autotrophic denitrification technologies aimed at treating industrial pollutants. He also works on real-time water quality monitoring, developing rapid detection equipment for COD, BOD, and toxicity. A notable innovation is the development of synchronous wastewater treatment and hydrogen production technologies, integrating environmental sustainability with clean energy generation. Additionally, he has contributed to the pretreatment of refractory industrial wastewater and the use of computational fluid dynamics for reactor optimization. Dr. Han’s multidisciplinary work combines chemical engineering, environmental science, and materials science, enabling the design of efficient, scalable, and eco-friendly solutions for water treatment. His focus on practical application, supported by a solid theoretical foundation, distinguishes his work in the environmental engineering field.

Publications Top Notes:

  1. Electrooxidation degradation of bisphenol A: pathways and toxicity analysisSeparation and Purification Technology, 2024

  2. Iron-carbon micro-electrolysis reactor for aniline wastewater: mechanism and pathwaysChinese Journal of Chemical Engineering, 2023

  3. Fe/C-MgCO₃ micro-electrolysis fillers for phosphorus removalEnvironmental Science and Pollution Research, 2022

  4. High-efficiency PbO₂ anode via Ce-GO doping: electrochemical study – Journal pending, 2022

  5. Integrated COD and BOD determination techniquePolish Journal of Environmental Studies, 2021

  6. Sulfate removal via internal circulation iron-carbon micro-electrolysisSeparation and Purification Technology, 2021

  7. Electro-coagulation of hydrolyzed polyacrylamide: optimization studyDesalination and Water Treatment, 2020

  8. Electrochemical oxidation of HPAM at Ti/SnO₂-Sb₂O₃/β-PbO₂ AnodeInt. J. Electrochemical Science, 2020

  9. Hydrodynamic simulation in micro-electrolysis reactorsChemical Engineering Journal, 2020

  10.  Micro-electrolysis biological fluidized bed for coking wastewaterJournal of Water Process Engineering, 2020

Conclusion:

Dr. Han Yanhe stands out as a highly qualified candidate for the Best Researcher Award. His innovative contributions in environmental engineering, particularly in wastewater treatment and electrochemical systems, are of high scientific value and societal relevance. Backed by strong academic output, international exposure, and sustained commitment to teaching, Dr. Han exemplifies the excellence this award seeks to recognize.

Athok Maarif | SARS-CoV-2 Infection | Best Researcher Award

Mr. Athok Maarif | SARS-CoV-2 Infection | Best Researcher Award

Mr. Athok Maarif, Tottori University, Japan

Athok Shofiudin Maarif is an emerging infectious disease researcher currently pursuing a PhD at the Graduate School of Medical Sciences, Tottori University, Japan. With a foundational background in medicine from Sebelas Maret University, Indonesia, Athok has developed a unique blend of clinical insight and advanced research capabilities. His work spans virology, immunology, microbiology, and antimicrobial resistance. He has co-authored several high-impact publications addressing timely global health challenges, particularly related to COVID-19. Athok is skilled in next-generation sequencing, viral culture, qRT-PCR, and flow cytometry, and he has hands-on experience in BSL-3 environments. He is recognized for his ability to bridge research with public health, earning multiple accolades and fellowships for his contributions to infectious disease control. His cross-cultural collaborations and commitment to translational research mark him as a promising leader in global health research.

Publication Profile: 

Orcid

Scopus

Strengths for the Award:

  1. High-Impact Research Publications:

    • Athok has authored and co-authored peer-reviewed papers in reputable journals such as Frontiers in Immunology, International Journal of Molecular Sciences, Yonago Acta Medica, and Journal of Infection and Chemotherapy.

    • His work is cutting-edge, addressing SARS-CoV-2 viral persistence, immune dynamics during Omicron, and microbiome analysis using next-generation sequencing.

  2. Technical Proficiency:

    • Mastery in NGS, qRT-PCR, flow cytometry, BSL-3 practices, and microbial DNA/RNA extraction.

    • Conducts complex lab work involving viral assays, PBMC isolation, and genomic studies, giving him versatility in laboratory-based infectious disease research.

  3. Strong International and Interdisciplinary Experience:

    • Research assistant roles in both Indonesia and Japan, combining clinical data, molecular science, and public health.

    • Recognized through fellowships and awards by USAID, INDOHUN, and international programs in Vietnam, Thailand, and Japan.

  4. Public Health & Global Health Perspective:

    • Active in One Health programs and waterborne disease prevention, showing ability to translate science into community impact.

    • Leads projects bridging microbiological research with real-world health policy and outreach.

⚙️ Areas for Improvement:

  1. Principal Investigator Role & Independent Research:

    • While he is a key contributor to multiple projects, Athok should aim to lead projects independently (e.g., as first or corresponding author in more papers).

    • Gaining competitive research grants or funding independently would strengthen his research autonomy.

  2. Broaden Beyond SARS-CoV-2:

    • His current research is primarily focused on COVID-19 and related microbiota studies.

    • Expanding into other emerging infectious diseases or antimicrobial resistance pathogens could widen his impact and relevance long-term.

  3. Increase Public and Policy Engagement Outputs:

    • While his research connects to public health, policy briefs, community health publications, or open-access science communication pieces would enhance visibility.

🎓 Education:

Athok Shofiudin Maarif is a PhD candidate in the Infectious Disease Department at the Faculty of Medicine, Tottori University, Japan, where he is expected to graduate in September 2025. His doctoral research focuses on the host-virus interface and antimicrobial resistance, utilizing cutting-edge genomic technologies. He previously earned his medical degree from Sebelas Maret University, Surakarta, Indonesia, graduating in April 2019. His education has emphasized both clinical medicine and research methodology, enabling him to tackle real-world infectious disease issues with scientific rigor. His early exposure to international academic programs, such as internships and short courses in Japan, Vietnam, and Thailand, enriched his global perspective and research aptitude. This educational foundation supports his current success in producing high-impact publications and executing interdisciplinary projects within both clinical and laboratory settings, further validating his dedication to global infectious disease control and scientific discovery.

💼 Professional Experience:

Athok Shofiudin Maarif has diverse experience in both research and field-based public health programs. Since 2021, he has worked as a Research Assistant in the Infectious Disease Department at Tottori University, Japan, where he manages experimental protocols, clinical sample data, and lab logistics involving pathogens at BSL-2/BSL-3 levels. His contributions include data analysis, coordination of laboratory workflow, and execution of molecular diagnostics such as qRT-PCR and viral assays. From 2018 to 2020, he served as a Research Assistant in the Public Health Department at Sebelas Maret University, organizing collaborative projects with government and health organizations in Indonesia. His interdisciplinary roles bridge laboratory and community-based research, underlining his capacity to integrate policy, education, and science in infectious disease management. This hybrid skillset enables him to effectively contribute to global health innovations and strengthens his candidacy for international research honors.

🏅 Awards & Honors:

Athok has received numerous prestigious awards that reflect both his scientific aptitude and social leadership. In 2019, he was named Best Participant in the International Short Course on Ecosystem One-Health in Thailand. He interned at Tottori University’s Infectious Disease Department in 2018 and earned the Best Project Award from USAID-INDOHUN for a community-based waterborne disease initiative. His cross-border engagements include a project on HIV/AIDS awareness for youth in Vietnam and a Research Fellowship under Sebelas Maret University’s Global Challenge Program. Earlier, in 2016, he was awarded Best Oral Presenter at a national HIV-AIDS educational program and recognized in a USAID disease outbreak preparedness course. These accolades showcase his leadership, international collaboration, and dedication to health innovation. His capacity to deliver results in both academic and field environments reflects his strength as a well-rounded researcher and strong candidate for the Best Researcher Award.

🔬 Research Focus:

Athok’s research centers on infectious diseases, particularly at the intersection of virology, immunology, and antimicrobial resistance. His PhD explores host–virus interactions in persistent SARS-CoV-2 infections, including viral evolution and gene expression profiling. He is also investigating the dynamics of natural killer cells during the Omicron phase, providing insights into immune responses. His broader work encompasses the impact of antibiotics like lascufloxacin on gut microbiota, development of rapid PCR diagnostics for COVID-19, and a systematic meta-analysis of antimicrobial resistance trends in Indonesia (2000–2023). He is also comparing resistant bacteria’s genetic profiles between Japan and Indonesia. Athok applies advanced technologies such as next-generation sequencing, flow cytometry, and BSL-3 viral culture techniques to tackle complex microbiological questions. His interdisciplinary, cross-national research approach aims to contribute practical solutions for infectious disease diagnostics, treatment, and public health strategy.

📚 Publications Top Notes:

  1. 🦠 Host–Virus Interface in Persistent SARS-CoV-2 Infections: Viral Characteristic Evolution and Gene Expression Profiling Analysis

  2. 🧪 Distinct Immunity Dynamics of Natural Killer Cells in Mild and Moderate COVID-19 Cases During the Omicron Variant Phase

  3. 🧬 Temporal Effects of Lascufloxacin on Human Gut and Salivary Microbiota: Analysis Using Next-Generation Sequencing Method

  4. 🧫 An Optimal Transport Medium for SARS-CoV-2 Detection in the Direct Method of Rapid Microfluidic PCR System

  5. 💊 Antimicrobial Resistance Trends in Indonesia (2000–2023): A Systematic Review and Meta-Analysis of Bacterial Resistance Across Antibiotic Classes (under review)

  6. 🧻 Comparison of Antimicrobial Resistance Characteristics and Genetic Profiles of Resistant Bacteria in Japan and Indonesia (ongoing)

📝 Conclusion:

Athok Shofiudin Maarif is an exceptionally promising early-career researcher in the field of infectious diseases. His strong international publication record, lab proficiency, and engagement in One Health initiatives make him highly suitable for the Best Researcher Award. His trajectory demonstrates significant leadership potential in translational virology and public health. With further development in grant leadership and broader disease focus, he will continue to emerge as a top-tier researcher in global infectious diseases.

Hülya Yaman | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Hülya Yaman | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Hülya Yaman , Bolu Abant Izzet Baysal University , Turkey

Assoc. Prof. Dr. Hülya Yaman is a seasoned academic and researcher specializing in Food Engineering, currently serving at Bolu Abant İzzet Baysal University, Turkey. With a robust background spanning over two decades, she has consistently contributed to dairy science, functional foods, traditional Turkish dairy products, and food processing technologies. Dr. Yaman has conducted post-doctoral research at The Ohio State University, USA, enriching her international experience and collaborative reach. Her work bridges academic rigor and industrial application, having held prior roles in quality control and production at leading food companies like Coca-Cola and Lamb Weston. Through a multidisciplinary approach, she has advanced knowledge in vibrational spectroscopy, cheese ripening, and food safety. She has authored numerous high-impact publications, participated in global conferences, and led pivotal research projects. Dr. Yaman is known for her scientific dedication, innovation in dairy technologies, and continuous contributions to Turkey’s and the global food science community.

Publication Profile: 

Orcid

✅ Strengths:

1. Extensive Academic Background:

  • Completed post-doctoral studies at The Ohio State University, a globally respected institution, focusing on advanced spectroscopic methods in food science.

  • Holds two Master’s degrees and a Ph.D., all centered around Food Engineering, showcasing academic versatility and depth.

2. Specialized Research Focus:

  • Her work has a focused yet diverse span — from spectroscopy techniques in dairy science to functional beverages, enzyme application in baking, and traditional cheese technologies.

  • Demonstrated expertise in food adulteration detection, milk protein analysis, and cheese ripening, which are of both scientific and industrial relevance.

3. High-Impact Publications & Collaborations:

  • Published in peer-reviewed journals such as Journal of Dairy Science, Food Bioscience, Frontiers in Nutrition, and International Journal of Dairy Technology.

  • Collaborated with internationally renowned researchers like Luis Rodriguez-Saona and Rafael Jiménez-Flores.

  • Indexed in Scopus and Elsevier databases, indicating a good research citation footprint.

4. Applied Research and Industry Relevance:

  • Many projects target real-world applications, such as cheese yield improvement, quality assessment using FTIR/Raman, and functional dairy product development.

  • Contributed to technology optimization of local cheeses (e.g., Mengen cheese, pasta keş), supporting gastronomy tourism and cultural heritage.

5. Research Project Leadership:

  • Led or co-led 7+ funded projects, which involved experimental work, optimization studies, and the development of rapid quality assessment tools.

  • Experience in project design, grant writing, and execution — a hallmark of a self-driven and effective researcher.

6. Interdisciplinary Approach:

  • Combines engineering, food chemistry, biotechnology, and gastronomy, which is crucial for modern food research.

7. Teaching and Mentorship:

  • Holds an Associate Professorship — indicative of teaching contributions and mentorship in vocational and university-level education.

⚠️ Areas for Improvement:

1. International Recognition & Visibility:

  • While the researcher has international postdoctoral experience, further global visibility could be enhanced through keynote speaking, editorial board memberships, or international patent filings.

2. Broader Publication Spectrum:

  • Consider targeting Q1 journals with high impact factors more consistently to enhance citation and recognition.

  • Expanding to multidisciplinary journals like Nature Food, Trends in Food Science & Technology, etc., could raise profile significantly.

3. Innovation/Commercialization Output:

  • While applied research is strong, it would be valuable to see more patents, commercial products, or startup spin-offs from the research outputs.

4. Student Supervision & PhD Mentoring:

  • The CV would benefit from specific mentions of PhD student supervision, thesis guidance, or mentoring early-career researchers.

📘 Education:

Dr. Hülya Yaman’s educational journey began with a Bachelor’s in Food Engineering from Hacettepe University (1991-1996). She earned her first Master’s (2002-2006) in Coach Training, focusing on the impact of arginine supplementation on exercise performance. Her second Master’s (2008-2010) in Food Engineering at Bolu Abant İzzet Baysal University explored changes in frozen goat milk. She pursued a Ph.D. (2011-2013) at the same university, optimizing the production technology of pasta keş, a traditional dairy product. Her academic excellence culminated in post-doctoral studies at The Ohio State University (2017-2019), where she specialized in advanced vibrational spectroscopy techniques for dairy product analysis. Her educational trajectory blends food science, nutritional performance, and food technology innovation, providing a solid foundation for interdisciplinary research and development in dairy and functional foods.

🛠️ Experience:

Dr. Yaman’s career spans academia and industry, with expertise in food processing, dairy product innovation, and quality assurance. Early in her career, she worked in quality control and production roles at leading Turkish food companies: Coca-Cola Ansan (Sales Rep, 1996–1998), Pak Tavuk (Quality Engineer, 1998–2000), Köytür (Production Engineer, 2000–2001), and Lamb Weston Doğuş (Quality Engineer, 2001). She transitioned to academia with her current position as Associate Professor in the Food Processing Department at Bolu Abant İzzet Baysal University. Her industrial background strengthens her academic research, particularly in traditional cheese technologies, milk product enhancement, and portable spectroscopy techniques. She has led various national and international projects, delivered numerous conference presentations, and collaborated with prominent researchers. Her combined experience in both practical and theoretical aspects of food science positions her as a thought leader and innovator in the field.

🔬 Research Focus:

Dr. Hülya Yaman’s research is primarily centered on dairy technology, particularly the optimization of traditional Turkish cheeses like keş and Mengen cheese, and the development of rapid analytical techniques for cheese ripening and milk adulteration detection. She is a pioneer in employing portable vibrational spectrometers (FTIR, NIR, Raman) for non-destructive food analysis, making significant strides in quality assurance, food safety, and product standardization. Her work on functional dairy beverages enriched with bioactive compounds also highlights her interest in health-focused product development. Recently, she’s explored high hydrostatic pressure treatments, fermented herb properties, and fungal enzymes in baking applications. Through collaborative efforts with international institutions like The Ohio State University, she contributes cutting-edge methodologies and scientific insights to both academic and commercial dairy sectors. Her interdisciplinary research links food engineering, spectroscopy, biochemistry, and microbiology, with a clear goal: enhancing food quality, authenticity, and functionality.

📚 Publication Top Notes:

  1. 🧀 Monitoring Turkish white cheese ripening by portable FT-IR spectroscopy

  2. 🧀 Ripening attributes of Turkish white cheese using miniaturized vibrational spectrometers

  3. 🍞 Fungal thermostable alpha amylase from hot springs: Impact on wheat bread quality

  4. 🐐 Detection of goat milk adulteration using vibrational spectroscopy & chemometrics

  5. 🧀 High hydrostatic pressure effects on ripening Turkish white cheese from various milks

  6. 🧀 Organic and fatty acid monitoring in white cheese using portable FTI Spectrometer

  7. 🧀 Optimization of Keş production technology for pasta

  8. 🥤 Whey-based functional beverage with soy isoflavones and phytosterols

  9. 🧀 Use of transglutaminase and rennet in white-brined cheese

  10. Effects of oral L-arginine on vasodilation and performance in soccer players

🏁 Conclusion:

Assoc. Prof. Dr. Hülya Yaman is an outstanding researcher with a strong foundation in dairy science, spectroscopy applications, and food processing technology. Her work is technically rich, practically relevant, and scientifically impactful — traits that align perfectly with the goals of a Best Researcher Award.

Recommendation: Highly suitable for nomination. A strategic push in global collaborations, high-impact publishing, and technology transfer could further elevate her already impressive academic stature.

Eman El-Wakil | Microbiology | Best Researcher Award

Assoc. Prof. Dr. Eman El-Wakil | Microbiology | Best Researcher Award

Assoc. Prof. Dr. Eman El-Wakil , Theodor Bilharz Research Institute , Egypt

Dr. Eman Sayed Shabrawy El-Wakil is an Associate Professor and Consultant of Medical Parasitology at the Theodor Bilharz Research Institute (TBRI), Egypt. Born on November 21, 1985, she has been deeply engaged in research and diagnostics of parasitic diseases, particularly focusing on molecular characterization, novel therapeutics, and gut microbiota-parasite interaction. With multiple peer-reviewed publications, she contributes to advancing parasitological science both in Egypt and internationally. She earned her M.D. in Medical Parasitology from Cairo University, and her scholarly reputation is supported by memberships and indexed profiles on ResearchGate, Google Scholar, Scopus, and ORCID. Dr. El-Wakil’s work has received notable accolades, including the prestigious TBRI award for the best doctoral research. She is also a reviewer for multiple journals and collaborates on multidisciplinary research tackling emerging parasitic threats. Her vision integrates research, education, and public health improvement through evidence-based parasitology.

Publication Profile:

Scopus

✅ Strengths for the Award:

Dr. Eman Sayed Shabrawy El-Wakil stands out as a prominent figure in Medical Parasitology, with an impressive track record in research, publication, and applied therapeutics. Her strengths include:

  • Robust Research Output: With over 12 peer-reviewed publications in high-impact international journals between 2023–2025, her work addresses critical parasitic diseases like Cryptosporidiosis, Trichinellosis, Toxoplasmosis, and Entamoeba infections.

  • Innovative Methodologies: She has pioneered green synthesis, nanoparticle-based therapies, in silico modeling, and immunomodulatory strategies, showcasing her multidimensional expertise.

  • Academic Leadership: As an Associate Professor and Consultant at TBRI, she contributes to teaching, mentoring, and national public health research priorities.

  • International Recognition: Indexed in Scopus, Google Scholar, ORCID, and Web of Science, and recipient of the TBRI Award for the best doctoral research in 2021.

  • Interdisciplinary Collaboration: Engaged in research across nanomedicine, pharmacology, microbiota-parasite interactions, and immunotherapy.

🔍 Areas for Improvement:

While Dr. El-Wakil’s profile is distinguished, some areas can be enhanced to strengthen her global impact:

  • Increased Global Engagement: Participation in more international collaborative projects, conferences, and consortia would amplify the reach of her research.

  • Grant Acquisition: Pursuing competitive research funding (e.g., WHO, NIH, EU Horizon) would facilitate larger-scale studies and clinical applications.

  • Patents and Translational Outputs: Exploring patenting opportunities for her innovative therapeutic agents could position her as a translational research leader.

🎓 Education:

Dr. El-Wakil earned her Master’s (M.Sc.) in Medical Parasitology with Excellent distinction in May 2015, and her Doctorate (M.D.) in Medical Parasitology in May 2018 from the Faculty of Medicine, Cairo University. Her educational path is marked by excellence in theoretical and applied parasitology, encompassing key disciplines like Molecular Parasitology, Immunology, and Medical Parasitology. Her M.D. thesis, titled “Isolation and Molecular Characterization of Free-Living Amoebae from Water Sources in Egypt”, reflected her early interest in environmental parasitology and public health. The academic structure of her doctoral program integrated critical courses in host-parasite interactions and advanced diagnostic techniques, equipping her with both field and laboratory expertise. Her education established a strong foundation for a career defined by innovation, critical thinking, and translational research in parasitic diseases.

💼 Experience:

Currently serving as an Associate Professor and Consultant at TBRI’s Parasitology Department, Dr. El-Wakil brings over a decade of expertise in diagnostics, molecular biology, and experimental parasitology. She operates within the Immunology and Drug Evaluation Division, where she contributes to therapeutic investigations and drug repurposing studies targeting helminths and protozoa. Her consultancy role extends to research mentorship, scientific reviews, and diagnostic innovations for parasitic infections in Egypt. She also works closely with governmental and academic institutions under the Ministry of Higher Education and Scientific Research. Her leadership roles in various inter-institutional projects have propelled the institute’s visibility in parasitology. She also manages collaborations involving nanotechnology, bioinformatics, and herbal medicine as potential parasitic treatments. Dr. El-Wakil exemplifies a blend of academic rigor and applied science, aligning her role with national health priorities and global research trends.

🏅 Honors and Awards:

Dr. El-Wakil was honored with the Theodor Bilharz Research Institute Award in 2021 for the best research derived from a doctoral dissertation—an acknowledgment of her innovation in parasitological research. This award recognized her pioneering work on free-living amoebae and her methodological precision. In addition to institutional awards, her research has been showcased in multiple open-access international journals, and she frequently receives commendations for excellence in experimental design and publication impact. Her work on novel anti-parasitic agents and immunotherapeutic approaches has attracted attention in scientific forums. She has also contributed to multi-author reviews on global health topics such as SARS-CoV-2 vaccines, highlighting her versatility as a researcher. Her awards reflect both her depth of knowledge and the real-world applicability of her research in enhancing public health outcomes.

🔬 Research Focus:

Dr. El-Wakil’s research concentrates on the epidemiology, molecular diagnostics, and therapeutic strategies for parasitic infections. Her work integrates natural product pharmacology, nanotechnology-based delivery systems, and immune modulation therapies. Her investigations cover a broad spectrum of parasites, from protozoa like Cryptosporidium and Entamoeba, to helminths such as Trichinella spiralis. Recent research includes green synthesis of nanoparticles, bioinformatics-based molecular docking, and gut microbiota-parasite interactions. A recurring theme in her research is the repurposing of existing drugs for parasitic treatment, evaluated both in vitro and in vivo. She also explores the interplay between host immunity and parasitic infection using molecular signaling pathways such as P2X7 receptors. Her focus on translational parasitology bridges basic research and therapeutic innovation, providing insights into both endemic and emerging infections in Egypt and beyond.

📚 Publications Top Notes:

  1. 🍊 Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect

  2. 🧬 Microbiota-Parasite Interaction: Implication of Secretory Immunoglobulin A and P2X7 Receptor Signaling

  3. 🌿 Repurposing Drugs to Treat Trichinellosis: In Vitro Analysis of Nifedipine and Chrysanthemum coronarium Extract

  4. 🧪 Prevalence and Molecular Identification of Entamoeba Species Complex in Egyptians

  5. 📊 Mapping Gut Parasitism Patterns in a Cohort of Egyptians

  6. 🍃 Annona Muricata Leaf as an Anti-Cryptosporidial Agent: In Silico and In Vivo Study

  7. 🌼 Prophylactic and Therapeutic Effects of Kaempferol on Experimental Trichinella Spiralis

  8. 💊 Surfactant Vesicles for Enhanced Antitoxoplasmic Effect of Norfloxacin

  9. 🧾 SARS-CoV-2 Vaccines from A to Z: A Review of the Current Challenges

  10. 💉 Albendazole and Berberine Nanoparticles in Experimental Trichinellosis

  11. 🌿 Therapeutic Efficacy of Silymarin on Intestinal and Muscular Phases of Trichinellosis

  12. 🧫 Trichinella spiralis Antigens for Inflammatory Bowel Disease: Immunotherapeutic and Prophylactic Potential

🧾 Conclusion:

Dr. Eman S. El-Wakil demonstrates excellence in research productivity, scientific innovation, and professional engagement. Her contributions to parasitology—especially in the field of therapeutic innovation using natural compounds and nanoparticles—mark her as an emerging leader in her field. Given her academic rigor, publication record, and commitment to tackling parasitic diseases of global health concern, she is an outstanding candidate for the Best Researcher Award.

Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Assist. Prof. Dr. Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Assist. Prof. Dr. Romain Villéger , Université de Poitiers , France

Dr. Romain Villéger is an Assistant Professor at the University of Poitiers, France, in the Ecology & Biology of Interactions (EBI) lab, within the Microorganisms-Hosts-Environments (MHE) team. With a Ph.D. from the University of Limoges, his work explores the intricate interactions between probiotics and host cells. He has held postdoctoral positions at the University of Bordeaux and the University of Texas Medical Branch, USA, focusing on microbiota-host relationships and metabolomics. Dr. Villéger’s research aims to unravel the role of bacterial interactions, particularly in the context of gastrointestinal health, microbiota, and cancer. His research has led to significant advancements in understanding microbial pathogenesis, including the effects of probiotics and endocrine disruptors on host cell metabolism. A dedicated researcher, he has contributed to numerous scientific publications and currently leads several high-impact projects on bacteria-host interactions.

Publication Profile:

Scopus

Strengths for the Award:

  1. Expertise in Metabolomics: Dr. Romain Villéger’s extensive work in metabolomics, especially in the context of host-bacteria interactions, positions him as a strong candidate for the Cell Metabolism Award. His research on bacterial influence on host cellular metabolism and gut microbiota interactions contributes significantly to the field of cellular metabolism.
  2. Innovative Research Contributions: His research, particularly on the metabolic changes during amoeba-Legionella interactions, showcases a novel approach to understanding microbial pathogenesis. By identifying metabolic vulnerabilities in pathogens, his work has the potential for therapeutic applications, thus addressing fundamental questions in cell metabolism.
  3. Multidisciplinary Approach: Dr. Villéger combines microbiology, immunology, and metabolomics, which enriches his contributions to cellular metabolism. His research is collaborative, evidenced by numerous projects across different institutions and fields, indicating a broad and innovative approach to the subject.
  4. Publications and Impact: He has a strong publication record, with numerous articles in peer-reviewed journals (19 publications), with high visibility in top-tier journals such as British Journal of Cancer, Frontiers in Cellular and Infection Microbiology, and Environmental Microbiology Reports. This demonstrates his influence and impact in the scientific community.
  5. Research Leadership: As the principal investigator of multiple projects, including those on the effects of phthalates on gut microbiota and cancer development, Dr. Villéger has demonstrated leadership in advancing scientific knowledge in areas that intersect with cell metabolism, host-microbe interactions, and metabolic changes in disease.

Areas for Improvement:

  1. Broader Clinical Translation: While his research shows deep insights into fundamental mechanisms, further work on translating these findings into practical clinical applications or therapeutic interventions would strengthen his impact in applied cellular metabolism.
  2. Interdisciplinary Team Development: While Dr. Villéger collaborates with many renowned researchers, fostering additional interdisciplinary partnerships could enrich his research by incorporating diverse techniques and perspectives from fields like drug development or personalized medicine.
  3. Expanding Metabolomic Toolkits: His research could benefit from exploring emerging and cutting-edge techniques in metabolomics, like single-cell analysis or multi-omics approaches, to gain deeper insights into cellular metabolism at the individual cell level.

Education:

Dr. Villéger completed his Ph.D. at the University of Limoges, where his thesis focused on the interactions between probiotics and host cells. His postdoctoral work spans institutions in France, the USA, and beyond, each contributing valuable insights into microbial-host dynamics and cellular microbiology. At the University of Bordeaux, he developed metabolomic approaches using GC/MS to study microbiota interactions. Later, at the University of Texas Medical Branch, he delved deeper into the effects of probiotics on intestinal homeostasis. Further postdoctoral experiences at the University of Clermont Auvergne involved examining the relationship between E. coli and colorectal cancer. Through these experiences, Dr. Villéger has gained expertise in microbiota research, cell biology, and metabolic analysis, providing a foundation for his ongoing work in the field. His education has provided a strong interdisciplinary framework, integrating microbiology, molecular biology, and toxicology into his research.

Experience:

Dr. Villéger has accumulated extensive experience in both academic and research settings. After earning his Ph.D. in 2014, he completed several postdoctoral positions, with notable work at the University of Bordeaux, where he pioneered metabolomics techniques for microbiota research. His tenure at the University of Texas Medical Branch expanded his focus to the effects of probiotics on intestinal homeostasis. Additionally, his work at the University of Clermont Auvergne involved exploring the connection between microbial interactions and cancer. Since joining the University of Poitiers in 2020 as an Assistant Professor, Dr. Villéger has led several research projects, including investigating the impact of endocrine disruptors on colorectal cancer development. He is also a leader in metabolomics and microbial pathogenesis, with a particular focus on bacteria-host interactions and microbiota modulation. His research has contributed to numerous publications and collaborations with institutions worldwide, showcasing his ability to manage complex research projects.

Research Focus:

Dr. Villéger’s research primarily focuses on bacteria-host interactions, gut microbiota, and cellular microbiology, with a special interest in how microbial populations affect host metabolism. His work integrates metabolomics, a powerful tool for studying metabolic processes, to better understand microbial influence on host cells. Dr. Villéger’s recent studies explore the role of oxidative stress in microbial infections, including Legionella pneumophila’s subversion of host immune defenses during infection. He has also investigated the impact of endocrine disruptors on microbial virulence, providing insights into the potential links between environmental factors and microbial pathogenesis. His contributions to understanding the microbiota-gut-brain axis, particularly in the context of colorectal cancer, emphasize the metabolic changes induced by bacterial interactions. Dr. Villéger’s research aims to identify biomarkers for disease and therapeutic interventions, with a broader goal of advancing precision medicine through a better understanding of the cellular and metabolic processes that underlie microbial-host dynamics.

Publications Top Notes:

  1. Legionella pneumophila subverts the antioxidant defenses of its amoeba host Acanthamoeba castellanii 💥🦠
  2. Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn’s Disease 🔬🧬
  3. Exposure to endocrine disruptors promotes biofilm formation and contributes to increased virulence of Pseudomonas aeruginosa 💧🦠
  4. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer 🧬🦠
  5. Effect of endocrine disruptors on bacterial virulence 🌿🧪
  6. Proteomic analysis of Acanthamoeba castellanii response to Legionella pneumophila infection 🔬🦠
  7. Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism 🧬🍊
  8. Microbiota medicine: towards clinical revolution 🌍💊
  9. Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis 🔬🦠
  10. Prebiotic Isomaltooligosaccharide Provides an Advantageous Fitness to the Probiotic Bacillus subtilis CU1 🍞🦠

Conclusion:

Dr. Romain Villéger is a highly qualified candidate for the Cell Metabolism Award. His research contributions in understanding microbial influence on cellular metabolism and gut health, combined with his innovative approach to metabolomics, make him stand out in the field. His work bridges basic science and potential clinical applications, positioning him as a key figure in the ongoing exploration of microbial and metabolic influences on host physiology. With some expansion into clinical applications and further exploration of new metabolomics techniques, his contributions could significantly impact both scientific knowledge and medical practice.